BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dang S, Malik A, Chen J, Qu J, Yin K, Cui L, Gu M. LncRNA SNHG15 Contributes to Immuno-Escape of Gastric Cancer Through Targeting miR141/PD-L1. Onco Targets Ther 2020;13:8547-56. [PMID: 32943878 DOI: 10.2147/OTT.S251625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Siri G, Yazdani O, Esbati R, Akhavanfar R, Asadi F, Adili A, Ebrahimzadeh F, Hosseini SME. A comprehensive review of the role of lncRNAs in gastric cancer (GC) pathogenesis, immune regulation, and their clinical applications. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.154221] [Reference Citation Analysis]
2 Chen X, Hu L, Mao X, Chen H, She Y, Chi H, Zeng H, Guo L, Han Y, Xu Y. Upregulated LINC00922 Promotes Epithelial-Mesenchymal Transition and Indicates a Dismal Prognosis in Gastric Cancer. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/1608936] [Reference Citation Analysis]
3 Peng L, Peng JY, Cai DK, Qiu YT, Lan QS, Luo J, Yang B, Xie HT, Du ZP, Yuan XQ, Liu Y, Yin D. Immune Infiltration and Clinical Outcome of Super-Enhancer-Associated lncRNAs in Stomach Adenocarcinoma. Front Oncol 2022;12:780493. [PMID: 35311149 DOI: 10.3389/fonc.2022.780493] [Reference Citation Analysis]
4 Yamaguchi H, Hsu J, Yang W, Hung M. Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat Rev Clin Oncol. [DOI: 10.1038/s41571-022-00601-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
5 Uhan S, Hauptman N. Metastatic EMT Phenotype Is Governed by MicroRNA-200-Mediated Competing Endogenous RNA Networks. Cells 2021;11:73. [PMID: 35011635 DOI: 10.3390/cells11010073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu Y, Ding W, Yu W, Zhang Y, Ao X, Wang J. Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. Mol Ther Oncolytics 2021;23:458-76. [PMID: 34901389 DOI: 10.1016/j.omto.2021.11.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
7 Chen D, Ping S, Xu Y, Wang M, Jiang X, Xiong L, Zhang L, Yu H, Xiong Z. Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications. Front Cell Dev Biol 2021;9:732036. [PMID: 34805143 DOI: 10.3389/fcell.2021.732036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Jiang W, Pan S, Chen X, Wang ZW, Zhu X. The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy. Mol Cancer 2021;20:116. [PMID: 34496886 DOI: 10.1186/s12943-021-01406-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 23.0] [Reference Citation Analysis]
9 Li S, Cao Y, Zhang H, Lu X, Wang T, Xu S, Kong T, Bo C, Li L, Ning S, Wang J, Wang L. Construction of lncRNA-Mediated ceRNA Network for Investigating Immune Pathogenesis of Ischemic Stroke. Mol Neurobiol 2021. [PMID: 34173933 DOI: 10.1007/s12035-021-02426-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]